Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

569 result(s) found, displaying 326 to 350

  • AusPAR: Pembrolizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pembrolizumab (rch)

  • AusPAR: Sarilumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sarilumab (rch)

  • AusPAR: Bosentan

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Bosentan

  • AusPAR: Sebelipase alfa

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Sebelipase alfa

  • AusPAR: Adalimumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab

  • AusPAR: Cladribine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cladribine

  • AusPAR: Dupilumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dupilumab

  • AusPAR: Suvorexant

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Suvorexant

  • AusPAR: Pembrolizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pembrolizumab [Keytruda]

  • AusPAR: Insulin degludec (rys)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for insulin degludec (rys)

  • AusPAR: Eluxadoline

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eluxadoline [Viberzi] (for irritable bowel syndrome with diarrhoea)

  • AusPAR: Trifluridine / Tipiracil

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Trifluridine/tipiracil [Lonsurf and Orcantas]

  • AusPAR: Reslizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Reslizumab

  • AusPAR: Tocilizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tocilizumab (rch)

  • AusPAR: Obinutuzumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Obinutuzumab

  • AusPAR: Guanfacine

    Australian public assessment report (AusPar)
    Australian public assessment report for Guanfacine

  • AusPAR: Palbociclib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Palbociclib [Ibrance]

  • AusPAR: Ranolazine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ranolazine

  • AusPAR: teduglutide

    Australian public assessment report (AusPar)
    Teduglutide [Revestive]

  • AusPAR: Phleum pratense

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Phleum pratense